CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
Yovis Capsules +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06283784
NCT06283784N/ACompleted

Double Blind, Randomized, Placebo Controlled Study To Evaluate The Efficacy of a Proprietary Mix of Live Probiotics in the Prophylaxis Of Diarrhea In Adult Patients Who Already Initiated An Oral Antibiotic Therapy

Biofarma·interventional·Posted Feb 28, 2024·Updated Mar 18, 2024

In Brief

A clinical study evaluating Yovis Capsules and Placebo for Diarrhea. Completed, enrolled 100 participants across 1 site.

Detailed Summary

This is a double blind, randomized, placebo-controlled study. One-hundred subjects are randomized to receive either YOVIS or placebo over a period of 10 days. The purpose is to determinate the efficacy of the treatment in subjects treated with antibiotic therapy, by measuring occurrence of Antibiotic Associated Diarrhoea (AAD) from baseline to the end of the observation period (28±2 days)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiarrhea
CountriesItaly

Timeline

N/ACompletedFinished
20222023202420252026
First PostedFeb 28, 2024
Enrollment StartSep 5, 2021
Primary CompletionNov 2, 2021
Study CompletionMay 18, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.3 years ago

Interventions

Yovis Capsulesother

Subjects will assume the active treatment for 10 consecutive days (1 capsule once daily) with a drop of water, preferably without food.

Placeboother

Subjects will assume the placebo treatment for 10 consecutive days (1 capsule once daily) with a drop of water, preferably without food.